查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1807537

心房中膈缺損症市場（按產品類型、治療類型、年齡層、最終用戶和缺損類型）—2025-2030 年全球預測

Atrial Septal Defect Market by Product Type, Treatment Type, Age Group, End User, Defect Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

心房中膈缺損症市場預計到 2024 年將達到 39.9 億美元，到 2025 年將達到 42.7 億美元，到 2030 年將達到 60.9 億美元，複合年成長率為 7.27%。

主要市場統計數據
基準年2024年 39.9億美元
預計2025年 42.7億美元
預計2030年 60.9億美元
複合年成長率（%） 7.27%

深入研究臨床、技術和病患動態，為了解心房中膈缺損症市場奠定基礎

心房中膈缺損症)是臨床實踐中最常見的先天性心臟疾病之一，涉及動態、解剖學和患者個體差異等複雜因素的相互作用。患有此缺陷的患者通常會出現一系列臨床表現，從無症狀到運動耐受性降低、心律不整和右心室超負荷。病人歷程如此多樣化，凸顯了精準診斷途徑和個人化治療性介入介入的必要性。

透過創新、政策演進和以病人為中心的治療策略，重塑心房中膈缺損症生態系統

心房中膈缺損症市場正在經歷一場變革性的轉變，這得益於器械工程的突破、報銷模式的轉變以及對以患者為中心的護理模式的重視。器械創新者正在突破微型化和生物相容性的極限，並融入先進的聚合物複合材料和形狀記憶合金，使其能夠無縫貼合房間隔的解剖結構。同時，從遠端血流動力學監測到人工智慧影像分析等數位健康工具的整合，使臨床醫生能夠個人化手術計劃並最佳化追蹤通訊協定。

評估 2025 年美國關稅對介入性心臟病學設備供應鏈、成本結構和策略市場定位的影響

美國將於2025年實施新的關稅，為心房中膈缺損症器械的供應鏈計算帶來了關鍵變數。對進口零件和成品徵收分級關稅，導致製造商從原料採購到最終器械組裝的各個環節成本上升。為此，領先的醫療設備製造商正在調整籌資策略，並與本地夥伴關係合作，以減輕關稅波動的影響，並確保零件的持續供應。

揭示自閉症領域的產品類型、治療方式、年齡層、最終用戶和缺陷變化的關鍵細分洞察

詳細的細分分析揭示了心房中膈缺損症市場的多面性。按產品類型分類，該市場包括心肺體外迴圈裝置、封堵裝置和診斷設備。在封堵解決方案中，阻塞設備與外科補片並列。外科補片又進一步分為球囊擴張型和自擴張式，而補片則可由生物或合成材料製成。診斷功能涵蓋心導管裝置、先進的影像系統和專用的超音波心動圖平台。這種層級結構凸顯了在不同技術叢集中進行有針對性創新的重要性。

了解美洲、歐洲、中東和非洲以及亞太地區心房中膈缺損症市場的區域差異

心房中膈缺損症)治療的區域動態呈現出顯著的異質性。在美洲，完善的報銷途徑、早期採用機構以及強大的臨床試驗網路，支援尖端設備技術的快速普及。這種環境促進了醫療中心與產業創新者之間的合作夥伴關係，從而加速了設備的迭代改進和真實世界證據的產生。

介紹推動心房中膈缺損症管理技術進步和協作方法的市場領導和新興創新者

心房中膈缺損症解決方案的競爭格局呈現兩極化：成熟醫療設備公司和敏捷的新參與企業。現有企業利用其深厚的臨床關係和廣泛的分銷網路，不斷改進器械設計和輸送系統。這些升級通常著重於改善器材貼合度、減小外形尺寸，並在置入過程中整合即時影像回饋。

可行的策略建議，以增強市場定位、推動創新並改善心房中膈缺損症治療的患者預後

產業領導者應優先投資微創設備平台，以降低手術複雜性並改善患者復原軌跡。將研發資源導向生物相容性材料和下一代輸送系統，有助於企業實現產品差異化，並滿足尚未滿足的臨床需求。此外，與契約製造製造商和物流專家建立策略夥伴關係關係，可以增強供應鏈在不斷變化的貿易政策中的韌性。

整合主要相關人員調查、二手文獻綜述和嚴格的資料檢驗過程的綜合調查方法

本分析基於嚴謹的研究框架，整合了主要研究方法和次要研究方法。主要研究包括對介入性心臟病專家、心胸外科醫生、採購專業人員、付款人和醫療保健管理人員進行結構化訪談和調查，以了解設備性能、臨床工作流程和經濟因素的真實觀點。此外，由臨床專家組成的共識小組對這些見解進行了補充，以檢驗關鍵發現並解讀新興趨勢。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 新型生物分解性分解封堵材料減少併發症，提高經導管封堵術的採用率
  • 增加對人工智慧心臟超音波圖的投資，以實現早期發現和個人化自閉症治療計劃
  • 越來越多的臨床試驗評估經皮裝置對患有複雜性心房中膈缺損症的成年患者的作用
  • 設備製造商和心臟中心在開發微創 ASD 修復技術方面的合作正在增多
  • 新興國家結構性心臟介入的報銷政策擴大將推動市場成長

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章心房中膈缺損症市場（依產品類型）

  • 心肺體外迴圈機
  • 封閉裝置
    • 阻塞設備
      • 球囊擴張型封堵器
      • 自膨脹式閉孔器
    • 手術補片
      • 生物補丁
      • 合成補片
  • 診斷設備
    • 心導管插入裝置
    • 心臟影像系統
    • 心臟超音波圖系統

第9章心房中膈缺損症市場（依治療類型）

  • 介入治療
  • 非介入治療

第10章。心房中膈缺損症市場（依年齡層）

  • 成人
  • 小兒科
    • 青春期
    • 嬰兒
    • 新生

第 11 章。心房中膈缺損症市場（按最終用戶）

  • 門診手術中心
  • 心臟中心
  • 醫院

第 12 章心房中膈缺損症市場（按缺損類型）

  • 冠狀竇
  • 原發孔
  • 第二口
  • 靜脈竇

13. 美國心房中膈缺損症市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲心房中膈缺損症市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太地區心房中膈缺損症市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • WL Gore & Associates, Inc.
    • Asklepion Pharmaceuticals, LLC
    • atHeart Medical AG
    • B. Braun Medical Inc.
    • Boston Scientific Corporation
    • Carag AG
    • Edwards Lifesciences
    • GE HealthCare Technologies, Inc.
    • Koninklijke Philips NV
    • Lepu Medical Technology（Beijing）Co., Ltd
    • Lifetech Scientific
    • Occlutech GmbH
    • Visionary Medtech Solutions
    • Weigao Meidcal international Co., Ltd

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-CA17E905E9C1

The Atrial Septal Defect Market was valued at USD 3.99 billion in 2024 and is projected to grow to USD 4.27 billion in 2025, with a CAGR of 7.27%, reaching USD 6.09 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 3.99 billion
Estimated Year [2025] USD 4.27 billion
Forecast Year [2030] USD 6.09 billion
CAGR (%) 7.27%

Laying the Foundation for Atrial Septal Defect Market Understanding Through Deep Dive into Clinical, Technological, and Patient Dynamics

Atrial septal defect represents one of the most prevalent congenital heart anomalies encountered in clinical practice, presenting an intricate interplay of hemodynamic, anatomical, and patient-specific factors. Patients with this defect often experience a spectrum of clinical manifestations, ranging from asymptomatic presentations to compromised exercise tolerance, arrhythmias, and right ventricular overload. These diverse patient journeys underscore the critical need for precise diagnostic pathways and tailored therapeutic interventions.

Advancements in diagnostic modalities, including enhancements in intracardiac echocardiography, sophisticated imaging software, and catheterization techniques, have facilitated earlier and more accurate detection of septal defects. At the same time, novel occlusion devices and bioengineered patches are redefining the interventional landscape, offering less invasive options and reduced recovery times. This technological momentum is paralleled by evolving clinical guidelines, which increasingly emphasize patient stratification based on defect size, anatomical location, and comorbid conditions.

Beyond technological and clinical progress, the economic and regulatory backdrop shapes the innovation trajectory. Healthcare payers and regulatory bodies are driving value-based reimbursement frameworks that reward demonstrable improvements in patient outcomes. Consequently, manufacturers and healthcare providers must align research and development initiatives with real-world evidence generation, forging a nexus between clinical efficacy and cost efficiency. This introductory overview sets the stage for a deeper exploration of transformative shifts, policy impacts, and actionable strategies within the atrial septal defect market.

Transformative Shifts Reshaping the Atrial Septal Defect Ecosystem Driven by Innovation, Policy Evolution, and Patient-Centric Care Strategies

The atrial septal defect market is undergoing transformative shifts propelled by breakthroughs in device engineering, shifts in reimbursement paradigms, and an intensified focus on patient-centered care models. Device innovators are pushing the boundaries of miniaturization and biocompatibility, incorporating advanced polymer composites and shape-memory alloys that conform seamlessly to septal anatomy. Simultaneously, the integration of digital health tools-ranging from remote hemodynamic monitoring to AI-enhanced imaging analyses-is enabling clinicians to personalize procedural plans and optimize follow-up protocols.

Concurrently, regulatory authorities in key markets are adopting more streamlined approval pathways for next-generation devices, contingent upon robust post-market surveillance and real-world data collection. These adjustments aim to balance rapid patient access with long-term safety validation. Payer ecosystems are realigning their criteria to support interventions that demonstrate quantifiable reductions in hospital readmissions and improved quality-adjusted life years. Value-based contracting models are incentivizing providers to prioritize durable, cost-effective solutions that deliver sustained clinical benefits.

Moreover, patient advocacy groups and multidisciplinary care teams are elevating the voice of patients in treatment planning, fostering shared decision-making frameworks. This patient empowerment trend underscores the importance of educational initiatives and transparent risk-benefit communication. Together, these transformative forces are reshaping the atrial septal defect landscape from a siloed, procedure-focused environment into an interconnected ecosystem centered on patient outcomes, evidence generation, and integrated care delivery.

Assessing the Impact of United States Tariffs in 2025 on Device Supply Chains, Cost Structures, and Strategic Market Positioning for Cardiac Interventions

The introduction of new tariff structures by the United States in 2025 has introduced a pivotal variable into the supply chain calculus for atrial septal defect devices. By imposing incremental duties on imported components and finished products, manufacturers are encountering elevated costs that reverberate from raw-material procurement through final device assembly. In response, leading device producers are reassessing their sourcing strategies, forging partnerships with regional suppliers to mitigate exposure to duty fluctuations and ensure continuity of component availability.

These strategic shifts are accompanied by renegotiations of commercial agreements with contract manufacturers and logistics providers, aiming to absorb or distribute tariff-related cost pressures. Some stakeholders have accelerated investments in domestic manufacturing capabilities, seeking to qualify for tariff exemptions associated with localized production. While these initiatives may require significant upfront capital, they promise resilience against future trade policy volatility and may unlock incentives tied to domestic job creation.

On the clinical front, hospitals and surgical centers are recalibrating purchasing committees and budget allocations to accommodate the revised cost profiles. Procurement teams are engaging in more rigorous total cost of ownership analyses, balancing device efficacy against lifecycle maintenance and potential tariff escalations. This collective realignment underscores a broader trend: the convergence of trade policy considerations with strategic supply chain management and fiscal stewardship.

Unveiling Key Segmentation Insights into Product Types, Treatment Modalities, Age Demographics, End Users, and Defect Variants in the ASD Arena

In-depth segmentation analysis reveals the multifaceted nature of the atrial septal defect market. When examined through the lens of product type, the landscape comprises cardiopulmonary bypass devices, closure devices, and diagnostic equipment. Within closure solutions, occluder devices stand alongside surgical patches; the former category breaks down further into balloon-expandable and self-expanding variants, while patches may be derived from biologic or synthetic materials. Diagnostic capabilities span cardiac catheterization equipment, advanced imaging systems, and dedicated echocardiography platforms. This layered hierarchy underscores the importance of targeted innovation across distinct technology clusters.

Treatment modalities further refine the market, splitting into interventional and non-interventional approaches. Interventional therapies harness catheter-based technologies and device implants to achieve defect closure with minimal invasiveness, whereas non-interventional options focus on pharmacologic management and monitoring to address hemodynamic burden. Age stratification also plays a defining role: adult and pediatric cohorts exhibit divergent clinical trajectories, with the latter subdivided into neonatal, infant, and adolescent categories, each with unique anatomical and physiological considerations.

End users span ambulatory surgical centers, dedicated cardiac centers, and hospital settings, reflecting varying infrastructure requirements and patient acuity levels. Defect type segmentation highlights coronary sinus, ostium primum, ostium secundum, and sinus venosus anomalies, each necessitating specialized therapeutic frameworks. Understanding these intersecting segmentation dimensions is critical for stakeholders seeking to tailor product development, direct clinical education, and refine market entry strategies.

Decoding Regional Variations in Atrial Septal Defect Markets Across Americas, Europe, Middle East & Africa, and Asia-Pacific Landscapes

Regional dynamics in the atrial septal defect space exhibit notable heterogeneity. In the Americas, well-established reimbursement pathways and early adopter institutions support rapid assimilation of cutting-edge device technologies, coupled with robust clinical trial networks. This environment fosters collaborative partnerships between medical centers and industry innovators, accelerating iterative device enhancements and real-world evidence generation.

Across Europe, the Middle East, and Africa, regulatory landscapes vary widely, from the European Union's centralized approval systems to region-specific health authority processes. This diversity presents both challenges and opportunities; agile manufacturers can navigate these processes by aligning on harmonized clinical dossiers while engaging with regional regulatory experts. Moreover, emerging markets within this zone show increasing adoption of minimally invasive therapies as healthcare infrastructure expands.

In the Asia-Pacific realm, rapid healthcare investment is driving capacity growth in tertiary care facilities, especially in urban centers. Yet cost-containment pressures remain prominent, prompting local manufacturers and multinational corporations to pursue tiered pricing models and technology transfers. Digital health initiatives, including teleconsultation and remote monitoring platforms, are also gaining traction, offering pathways to bridge resource gaps and extend specialist expertise to broader patient populations. These diverse regional contours highlight the imperative for tailored market approaches that resonate with local clinical, economic, and regulatory contexts.

Profiling Market Leaders and Emerging Innovators Driving Technological Advances and Collaborative Approaches in Atrial Septal Defect Management

The competitive arena for atrial septal defect solutions is characterized by a blend of established medical device companies and agile newcomers. Incumbent firms have leveraged deep clinical relationships and expansive distribution networks to introduce iterative upgrades in device design and delivery systems. These upgrades often focus on enhancing device conformability, reducing profile size, and integrating real-time imaging feedback during implantation.

At the same time, emerging players are capturing attention through disruptive innovations such as bioresorbable occluders and next-generation polymer patches that promote tissue regeneration. Collaborative preclinical studies with academic institutions are underpinning these advances, providing critical safety and efficacy data. Additionally, there is a discernible shift toward digital integration, with companies embedding sensor technologies and connectivity features into their devices to support remote monitoring and patient engagement applications.

Strategic alliances, joint ventures, and selective acquisitions have become commonplace as organizations strive to fortify their product portfolios and accelerate entry into adjacent markets. This collaborative ecosystem is fostering cross-disciplinary R&D efforts that marry materials science, engineering prowess, and clinical insights. As a result, the market is witnessing a proliferation of modular solutions that offer scalability across clinical settings, from pediatric catheterization labs to high-throughput surgical suites.

Actionable Strategic Recommendations to Elevate Market Positioning, Foster Innovation, and Enhance Patient Outcomes in Atrial Septal Defect Care

Industry leaders should prioritize investment in minimally invasive device platforms that reduce procedural complexity and enhance patient recovery trajectories. By channeling R&D resources toward bioadaptive materials and next-generation delivery systems, organizations can differentiate their product offerings and address unmet clinical needs. Furthermore, forging strategic partnerships with contract manufacturers and logistics specialists will bolster supply chain resilience amid shifting trade policies.

Parallel to product innovation, developing comprehensive real-world evidence frameworks is essential. This requires collaboration with key opinion leaders, registry coordinators, and payers to capture longitudinal patient outcomes and cost metrics. Demonstrating sustained value through outcomes data will facilitate adoption in value-based reimbursement models and reinforce clinical trust.

Engaging patient advocacy groups and multidisciplinary care teams early in the development cycle can refine product design and ensure alignment with patient priorities. Finally, exploring geographic expansion opportunities in high-growth regions demands customized market access strategies that respect local regulatory nuances and affordability dynamics. Implementing these recommendations will position organizations to navigate market complexities, foster clinician partnerships, and ultimately deliver superior care for patients with atrial septal defects.

Comprehensive Research Methodology Integrating Primary Stakeholder Engagement, Secondary Literature Review, and Rigorous Data Validation Processes

This analysis is grounded in a rigorous research framework combining primary and secondary methodologies. Primary research involved structured interviews and surveys with interventional cardiologists, cardiothoracic surgeons, procurement specialists, payers, and healthcare administrators to capture real-world perspectives on device performance, clinical workflows, and economic considerations. These insights were complemented by consensus panels with clinical experts to validate key findings and interpret emerging trends.

Secondary research encompassed an exhaustive review of peer-reviewed journals, regulatory filings, conference proceedings, patent databases, and company disclosures to construct a robust evidence base. Publicly available healthcare datasets and procedural registries were interrogated to identify utilization patterns and geographic adoption curves. Data triangulation techniques were applied throughout to reconcile discrepancies between sources and enhance the credibility of conclusions.

Quality control processes included systematic cross-validation of quantitative data points and iterative reviews by an internal research governance committee. Expert validation workshops provided additional scrutiny, ensuring that assumptions, segmentation frameworks, and strategic recommendations reflect the current state of the atrial septal defect market and are poised to withstand future shifts.

The landscape of atrial septal defect management is defined by concurrent forces of innovation, policy evolution, and shifting patient expectations. Advancements in device engineering and diagnostic modalities continue to drive clinical adoption, while evolving reimbursement frameworks are incentivizing tangible improvements in long-term patient outcomes. Supply chain realignments, influenced by recent trade policy changes, underscore the importance of agility and domestic capability expansion to mitigate cost pressures.

Segmentation insights highlight the multifaceted nature of this market, from diverse product categories and treatment pathways to nuanced age and defect-type considerations. Regional analyses reveal distinct growth drivers and access barriers, necessitating tailored approaches in the Americas, Europe, Middle East & Africa, and Asia-Pacific contexts. Meanwhile, the interplay between established players and emerging innovators is catalyzing collaborative advances that align engineering breakthroughs with clinical evidence.

Collectively, these insights form an integrated perspective on market dynamics, strategic imperatives, and areas of opportunity. Organizations that embrace data-driven decision-making, cultivate stakeholder partnerships, and invest in patient-centric innovation are best positioned to thrive in this evolving ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growth in transcatheter closure adoption driven by novel biodegradable occluders reducing complications
  • 5.2. Rising investment in AI-enabled echocardiography for early detection and personalized ASD treatment planning
  • 5.3. Increased clinical trials evaluating percutaneous device performance in adult patients with complex atrial septal defects
  • 5.4. Surge in collaboration between device manufacturers and cardiology centers to develop minimally invasive ASD repair techniques
  • 5.5. Expansion of reimbursement policies for structural heart interventions fueling market growth in emerging economies

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Atrial Septal Defect Market, by Product Type

  • 8.1. Introduction
  • 8.2. Cardiopulmonary Bypass Devices
  • 8.3. Closure Devices
    • 8.3.1. Occluder Devices
      • 8.3.1.1. Balloon-Expandable Occluders
      • 8.3.1.2. Self-Expanding Occluders
    • 8.3.2. Surgical Patches
      • 8.3.2.1. Biologic Patches
      • 8.3.2.2. Synthetic Patches
  • 8.4. Diagnostic Devices
    • 8.4.1. Cardiac Catheterization Equipment
    • 8.4.2. Cardiac Imaging Systems
    • 8.4.3. Echocardiography Systems

9. Atrial Septal Defect Market, by Treatment Type

  • 9.1. Introduction
  • 9.2. Interventional Treatment
  • 9.3. Non-Interventional Treatment

10. Atrial Septal Defect Market, by Age Group

  • 10.1. Introduction
  • 10.2. Adult
  • 10.3. Pediatric
    • 10.3.1. Adolescent
    • 10.3.2. Infant
    • 10.3.3. Neonatal

11. Atrial Septal Defect Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Cardiac Centers
  • 11.4. Hospitals

12. Atrial Septal Defect Market, by Defect Type

  • 12.1. Introduction
  • 12.2. Coronary Sinus
  • 12.3. Ostium Primum
  • 12.4. Ostium Secundum
  • 12.5. Sinus Venosus

13. Americas Atrial Septal Defect Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Atrial Septal Defect Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Atrial Septal Defect Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. W. L. Gore & Associates, Inc.
    • 16.3.3. Asklepion Pharmaceuticals, LLC
    • 16.3.4. atHeart Medical AG
    • 16.3.5. B. Braun Medical Inc.
    • 16.3.6. Boston Scientific Corporation
    • 16.3.7. Carag AG
    • 16.3.8. Edwards Lifesciences
    • 16.3.9. GE HealthCare Technologies, Inc.
    • 16.3.10. Koninklijke Philips N.V.
    • 16.3.11. Lepu Medical Technology (Beijing) Co., Ltd
    • 16.3.12. Lifetech Scientific
    • 16.3.13. Occlutech GmbH
    • 16.3.14. Visionary Medtech Solutions
    • 16.3.15. Weigao Meidcal international Co., Ltd

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. ATRIAL SEPTAL DEFECT MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. ATRIAL SEPTAL DEFECT MARKET: RESEARCHAI
  • FIGURE 26. ATRIAL SEPTAL DEFECT MARKET: RESEARCHSTATISTICS
  • FIGURE 27. ATRIAL SEPTAL DEFECT MARKET: RESEARCHCONTACTS
  • FIGURE 28. ATRIAL SEPTAL DEFECT MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. ATRIAL SEPTAL DEFECT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIOPULMONARY BYPASS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIOPULMONARY BYPASS DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY BALLOON-EXPANDABLE OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY BALLOON-EXPANDABLE OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SELF-EXPANDING OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SELF-EXPANDING OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY BIOLOGIC PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY BIOLOGIC PATCHES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYNTHETIC PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYNTHETIC PATCHES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIAC CATHETERIZATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIAC CATHETERIZATION EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIAC IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIAC IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY ECHOCARDIOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY ECHOCARDIOGRAPHY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY INTERVENTIONAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY INTERVENTIONAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY NON-INTERVENTIONAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY NON-INTERVENTIONAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CORONARY SINUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CORONARY SINUS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OSTIUM PRIMUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OSTIUM PRIMUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OSTIUM SECUNDUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OSTIUM SECUNDUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SINUS VENOSUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SINUS VENOSUS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 257. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 259. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 271. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 273. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 275. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 277. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 279. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 281. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 283. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 285. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 289. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 291. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 293. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 295. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 296. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 297. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 301. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 302. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 303. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 305. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 311. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 312. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 313. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 314. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-2030 (USD MILLION)
  • TABLE 315. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 316. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
  • TABLE 317. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 320. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 321. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
  • TABLE 322. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
  • TABLE 323. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 325. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 329. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 330. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 331. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2024 (USD MILLION)
  • TABLE 332. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2025-2030 (USD MILLION)
  • TABLE 333. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2024 (USD MILLION)
  • TABLE 334. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2025-20